Volume 39 Issue 10
Oct.  2023
Turn off MathJax
Article Contents
SUN Shu-xian, GU Xiao-qun, QIAN Pei-yao, YU Xue-rui, ZHENG Jie, ZHAO Qian, LI Jia-yu, HONG Min. Exploring the Target and Mechanism of Sanfeng Tongqiao Dropping Pills in the Treatment of Allergic Rhinitis Based on Systematic Pharmacological Methods[J]. Journal of Nanjing University of traditional Chinese Medicine, 2023, 39(10): 999-1005. doi: 10.14148/j.issn.1672-0482.2023.0999
Citation: SUN Shu-xian, GU Xiao-qun, QIAN Pei-yao, YU Xue-rui, ZHENG Jie, ZHAO Qian, LI Jia-yu, HONG Min. Exploring the Target and Mechanism of Sanfeng Tongqiao Dropping Pills in the Treatment of Allergic Rhinitis Based on Systematic Pharmacological Methods[J]. Journal of Nanjing University of traditional Chinese Medicine, 2023, 39(10): 999-1005. doi: 10.14148/j.issn.1672-0482.2023.0999

Exploring the Target and Mechanism of Sanfeng Tongqiao Dropping Pills in the Treatment of Allergic Rhinitis Based on Systematic Pharmacological Methods

doi: 10.14148/j.issn.1672-0482.2023.0999
  • Received Date: 2023-01-19
    Available Online: 2023-11-10
  •   OBJECTIVE  To screen the active components of Sanfeng Tongqiao (SFTQ) by using network pharmacological method and to investigate the target and mechanism of SFTQ in the treatment of allergic rhinitis (AR).  METHODS  The active components and targets of SFTQ were screened by TCMSP. TCMSP and TTD database were used to screen AR-related therapeutic targets. SFTQ active components-AR target network was constructed by Cytoscape to predict potential targets. KEGG pathway enrichment analysis was performed on Davidv 6.8 database. An AR mouse model was established, and different doses of SFTQ were used for intervention during the stimulation period. The results were evaluated through behavioral indicators, pathological sections, HE staining, peripheral blood EOS and IgE levels, and the number of ILC2 in cervical lymph nodes.  RESULTS  42 active components and 16 potential targets were identified. KEGG enrichment analysis revealed 18 potential signaling pathways involving T cell receptor signaling pathway, HIF-1 signaling pathway, etc. In vivo, SFTQ significantly reduced the frequency of sneezing and rubbing, the degree of mucosal thickening, peripheral blood EOS, IgE level and the amount of ILC2 in cervical lymph nodes.  CONCLUSION  Using systems pharmacology methods, the study revealed the multi-component, multi-target, and multi-pathway characteristics of SFTQ in treating AR, providing possible targets and active components for the mechanism study of SFTQ, and laying the foundation for a more comprehensive understanding and application of this prescription.

     

  • loading
  • [1]
    HELLINGS PW, KLIMEK L, CINGI C, et al. Non-allergic rhinitis: Position paper of the European academy of allergy and clinical immunology[J]. Allergy, 2017, 72(11): 1657-1665. doi: 10.1111/all.13200
    [2]
    GREINER AN, HELLINGS PW, ROTIROTI G, et al. Allergic rhinitis[J]. Lancet, 2011, 378(9809): 2112-2122. doi: 10.1016/S0140-6736(11)60130-X
    [3]
    刘静. 基于整体观念变应性鼻炎的中医辨证论治[J]. 山东大学耳鼻喉眼学报, 2017, 31(3): 28-30. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYU201703007.htm

    LIU J. Treatment of allergic rhinitis using syndrome differentiation based on the concept of "holism"in TCM[J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(3): 28-30. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYU201703007.htm
    [4]
    谢铮. 黄芩汤提取物加减滴鼻液对实验性变应性鼻炎豚鼠模型的影响[D]. 北京: 北京中医药大学, 2010.

    XIE Z. Effect of Huangqin Decoction extract on Guinea pig model of experimental allergic rhinitis[D]. Beijing: Beijing University of Chinese Medicine, 2010.
    [5]
    于萍, 刘东. 治疗过敏性鼻炎验方[J]. 中国民间疗法, 2018, 26(14): 5. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMJL201814004.htm

    YU P, LIU D. Prescription for treating allergic rhinitis[J]. China's Naturopathy, 2018, 26(14): 5. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMJL201814004.htm
    [6]
    张翠新, 王庆国. 王庆国教授治疗过敏性鼻炎经验总结[J]. 中国医药导报, 2019, 16(18): 125-128, 132. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201918032.htm

    ZHANG CX, WANG QG. Professor Wang Qingguo' s experience in the treatment of allergic rhinitis[J]. China Med Her, 2019, 16(18): 125-128, 132. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201918032.htm
    [7]
    WANG C, REN Q, CHEN XT, et al. System pharmacology-based strategy to decode the synergistic mechanism of Zhi-Zhu Wan for functional dyspepsia[J]. Front Pharmacol, 2018, 9: 841. doi: 10.3389/fphar.2018.00841
    [8]
    ALAM S, KHAN F. QSAR, docking, ADMET, and system pharmacology studies on tormentic acid derivatives for anticancer activity[J]. J Biomol Struct Dyn, 2018, 36(9): 2373-2390. doi: 10.1080/07391102.2017.1355846
    [9]
    RU JL, LI P, WANG JN, et al. TCMSP: A database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform, 2014, 6: 13. doi: 10.1186/1758-2946-6-13
    [10]
    XU X, ZHANG WX, HUANG C, et al. A novel chemometric method for the prediction of human oral bioavailability[J]. Int J Mol Sci, 2012, 13(6): 6964-6982. doi: 10.3390/ijms13066964
    [11]
    WANG YH, LI Y, DING J, et al. Prediction of binding affinity for estrogen receptor alpha modulators using statistical learning approaches[J]. Mol Divers, 2008, 12(2): 93-102. doi: 10.1007/s11030-008-9080-1
    [12]
    YAMANISHI Y, KOTERA M, KANEHISA M, et al. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework[J]. Bioinformatics, 2010, 26(12): i246-i254. doi: 10.1093/bioinformatics/btq176
    [13]
    LIPINSKI CA, LOMBARDO F, DOMINY BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1[J]. Adv Drug Deliv Rev, 2001, 46(1/2/3): 3-26.
    [14]
    GILL AL, VERDONK M, BOYLE RG, et al. A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical development[J]. Curr Top Med Chem, 2007, 7(14): 1408-1422. doi: 10.2174/156802607781696819
    [15]
    YU H, CHEN JX, XU X, et al. A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data[J]. PLoS ONE, 2012, 7(5): e37608. doi: 10.1371/journal.pone.0037608
    [16]
    SONG WJ, NI SL, FU YL, et al. Uncovering the mechanism of Maxing Ganshi Decoction on asthma from a systematic perspective: A network pharmacology study[J]. Sci Rep, 2018, 8(1): 17362. doi: 10.1038/s41598-018-35791-9
    [17]
    JIA ZR, WANG XT, WANG XY, et al. Calycosin alleviates allergic contact dermatitis by repairing epithelial tight junctions via down-regulating HIF-1α[J]. J Cell Mol Med, 2018, 22(9): 4507-4521. doi: 10.1111/jcmm.13763
    [18]
    张春辉, 邢雪琨, 张慧. 黄芩的药理作用研究[J]. 中兽医医药杂志, 2020, 39(2): 98-100. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSZZ202002034.htm

    ZHANG CH, XING XK, ZHANG H. Pharmacological effects of Radix scutellariae[J]. J Tradit Chin Vet Med, 2020, 39(2): 98-100. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSZZ202002034.htm
    [19]
    任晗堃, 刘宇红, 孟宏, 等. 荆芥复方提取液的抗敏功效研究[J]. 轻工学报, 2016, 31(4): 44-48. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZQB201604007.htm

    REN HK, LIU YH, MENG H, et al. Study on anti-allergy efficacy of Nepeta cataria prescriptions[J]. J Light Ind, 2016, 31(4): 44-48. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZQB201604007.htm
    [20]
    HALIM TYF, HWANG YY, SCANLON ST, et al. Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses[J]. Nat Immunol, 2016, 17(1): 57-64.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(8)

    Article Metrics

    Article views (191) PDF downloads(20) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return